U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07131657) titled 'Ropiclobet for Regional Anesthesia and Post-Operative Pain Control in Upper Extremity Surgery' on July 31.
Brief Summary: This is a national, single-center, single-arm, open-label Phase II clinical trial designed to evaluate the efficacy and safety of Ropiclobet, a fixed-dose injectable solution containing Ropivacaine HCl, Betamethasone Sodium Phosphate, and Clonidine HCl.
The study includes three non-randomized dose groups and will enroll a total of 60 adult volunteers undergoing upper extremity surgery (arm, elbow, forearm, or hand). All participants will receive a single administration of Ropiclobet via supraclavicular brachial ...